Dutch-Swiss start-up Cradle has raised €22 million ($24 million) in first-round financing to develop its generative ...

Argenx has been riding high of late thanks to buoyant sales growth for its Vyvgart therapy for muscle-wasting disease ...

AbbVie is preparing to file for accelerated approval of telisotuzumab vedotin (Teliso-V) as a treatment for some patients ...

The Ministry of Health, Labour and Welfare (MHLW) gave the green light to CSL and Arcturus’ COVID-19 vaccine ARCT-154 – also ...

Karuna Therapeutics said this morning that the FDA has formally started its review of KarXT, aiming to become the first drug ...

Andrew Nixon, global head of biotherapeutics discovery at Boehringer, said that IBM “share our vision of making in silico ...

The probe is directed at all CAR-Ts currently on the US market, including those that target CD19 as well as BCMA, which are ...

Pfizer spin-out SpringWorks Therapeutics has its first approved product after getting a green light from the FDA for Ogsiveo, ...

Now, with two supporting phase 3 trials, the way is cleared to file for regulatory approval in the US and other world markets ...

While there have been massive strides forward in treating cancer in the last decades – with a doubling in survival rates in ...

A reliable and sustainable clinical trial system plays a pivotal role in supporting patients with unmet needs. The lack of a ...

Veeva Systems’ Commercial Summit returned to Madrid for 2023, with over 1,500 life sciences industry professionals in ...